Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,454 | 10,021 | 4,497 | 5,806 | 0 |
| Marketable Securities | 46 | 45 | 43 | 42 | 0 |
| Receivables | 70 | 155 | 52 | 45 | 0 |
| TOTAL | $10,897 | $10,249 | $5,117 | $6,313 | $0 |
| Non-Current Assets | |||||
| PPE Net | 348 | 374 | 385 | 404 | N/A |
| Intangibles | 1,086 | 1,110 | 1,089 | 1,087 | 0 |
| Other Non-Current Assets | 15 | 15 | 14 | 0 | 0 |
| TOTAL | $1,448 | $1,498 | $1,487 | $1,490 | $N/A |
| Total Assets | $12,345 | $11,747 | $6,604 | $7,803 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,636 | 2,077 | 1,803 | 1,607 | 0 |
| TOTAL | $1,714 | $2,154 | $1,874 | $1,676 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 1,764 | 0 | 0 | 0 |
| TOTAL | $216 | $2,003 | $236 | $248 | $N/A |
| Total Liabilities | $1,931 | $4,157 | $2,110 | $1,924 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16 | 14 | 14 | N/A | N/A |
| Common Shares | 60,587 | 58,008 | 53,065 | 53,065 | 0 |
| Retained earnings | -71,594 | -68,492 | -66,249 | -64,649 | 0 |
| Other shareholders' equity | 129 | 129 | -172 | -302 | 0 |
| TOTAL | $10,415 | $7,591 | $4,494 | $5,878 | $0 |
| Total Liabilities And Equity | $12,345 | $11,747 | $6,604 | $7,803 | $0 |